Different effects of rosiglitazone and metformin on adipose tissue glucose uptake in type 2 diabetes

被引:0
|
作者
Yuan, MS
Melendez, PA
Iwamoto, M
Lee, JS
Shoelson, SE
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
585
引用
收藏
页码:A145 / A145
页数:1
相关论文
共 50 条
  • [41] Addition of rosiglitazone to glimepirid and metformin combination therapy in type 2 diabetes
    Orbay, E
    Sargin, M
    Sargin, H
    Gözü, H
    Bayramiçli, OU
    ENDOCRINE JOURNAL, 2004, 51 (06) : 521 - 527
  • [42] Rosiglitazone plus metformin to prevent type 2 diabetes mellitus Reply
    Zinman, Bernard
    LANCET, 2010, 376 (9750): : 1388 - 1388
  • [43] Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes
    Gómez-Perez, FJ
    Fanghänel-Salmón, G
    Barbosa, JA
    Montes-Villarreal, J
    Berry, RA
    Warsi, G
    Gould, EM
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2002, 18 (02) : 127 - 134
  • [44] Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study
    Weissman, P
    Goldstein, BJ
    Rosenstock, J
    Waterhouse, B
    Cobitz, AR
    Wooddell, MJ
    Strow, LJ
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (12) : 2029 - 2035
  • [45] Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes
    Cinti, Francesca
    Leccisotti, Lucia
    Sorice, Gian Pio
    Capece, Umberto
    D'Amario, Domenico
    Lorusso, Margherita
    Gugliandolo, Shawn
    Morciano, Cassandra
    Guarneri, Andrea
    Guzzardi, Maria Angela
    Mezza, Teresa
    Capotosti, Amedeo
    Indovina, Luca
    Ferraro, Pietro Manuel
    Iozzo, Patricia
    Crea, Filippo
    Giordano, Alessandro
    Giaccari, Andrea
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [46] Dapagliflozin treatment is associated with a reduction of epicardial adipose tissue thickness and epicardial glucose uptake in human type 2 diabetes
    Francesca Cinti
    Lucia Leccisotti
    Gian Pio Sorice
    Umberto Capece
    Domenico D’Amario
    Margherita Lorusso
    Shawn Gugliandolo
    Cassandra Morciano
    Andrea Guarneri
    Maria Angela Guzzardi
    Teresa Mezza
    Amedeo Capotosti
    Luca Indovina
    Pietro Manuel Ferraro
    Patricia Iozzo
    Filippo Crea
    Alessandro Giordano
    Andrea Giaccari
    Cardiovascular Diabetology, 22
  • [47] Effect of Bariatric Surgery on Adipose Tissue Glucose Metabolism in Different Depots in Patients With or Without Type 2 Diabetes
    Dadson, Prince
    Landini, Linda
    Helmio, Mika
    Hannukainen, Jarna C.
    Immonen, Heidi
    Honka, Miikka-Juhani
    Bucci, Marco
    Savisto, Nina
    Soinio, Minna
    Salminen, Paulina
    Parkkola, Riitta
    Pihlajamaki, Jussi
    Iozzo, Patricia
    Ferrannini, Ele
    Nuutila, Pirjo
    DIABETES CARE, 2016, 39 (02) : 292 - 299
  • [48] Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes
    Zirui Hao
    Yue Sun
    Guiping Li
    Yuli Shen
    Yingzhen Wen
    Yan Liu
    BMC Endocrine Disorders, 22
  • [49] Effects of canagliflozin and metformin on insulin resistance and visceral adipose tissue in people with newly-diagnosed type 2 diabetes
    Hao, Zirui
    Sun, Yue
    Li, Guiping
    Shen, Yuli
    Wen, Yingzhen
    Liu, Yan
    BMC ENDOCRINE DISORDERS, 2022, 22 (01)
  • [50] Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone
    Hällsten, K
    Virtanen, KA
    Lönnqvist, F
    Janatuinen, T
    Turiceanu, M
    Rönnemaa, T
    Viikari, J
    Lehtimaki, T
    Knuuti, J
    Nuutila, P
    DIABETIC MEDICINE, 2004, 21 (12) : 1280 - 1287